Skip to content
Recall Observatory FDA recall evidence

Drug product

Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-count bottles (NDC: 68788-7781-8), Rx only, Mfg: Dr. Reddy's Laboratories Limited.

D-0894-2023

June 26, 2023

Class II

Product summary

Firm
Preferred Pharmaceuticals, Inc.
Event
Event 92625
Status
Ongoing
Classification
Class II
Quantity
541 Bottles
Official record key
drug-enforcement:D-0894-2023

Official wording

Reason: Failed Stability Specifications

Code information: Lot#: a) H1621S, Exp: 12/31/2023; b) H2321C, Exp: 12/31/2023; c) H0421B, Exp: 12/31/2023; d) H1721E, H1921T, H3121M, Exp: 12/31/2023, e) H2021G, Exp: 12/31/2023

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Stability Specifications